Get the Stockscreener App
59.24
1.17%
0.9319
Global X Genomics Biotechnology Etf stock is traded at $59.24, with a volume of 5,895.
It is up +1.17% in the last 24 hours and up +7.41% over the past month.
See More
Previous Close:
$58.31
Open:
$58.36
24h Volume:
5,895
Relative Volume:
0.24
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.29%
1M Performance:
+7.41%
6M Performance:
+27.36%
1Y Performance:
+58.49%
1-Day Range:
$58.29
$59.22
1-Week Range:
$57.86
$59.99
52-Week Range:
$36.00
$59.99
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Name
Global X Genomics Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
58.99 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
382.23 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
772.98 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
776.65 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
307.91 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
730.02 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Stock (GNOM) Latest News
Global X Genomics & Biotechnology UCITS ETFUSDChart Real-time | ETF | GNOG | IE00BM8R0N95 - marketscreener.com
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
Global X Genomics & Biotechnology ETF (GNOM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Precision Trading with Global X Genomics & Biotechnology Etf (GNOM) Risk Zones - Stock Traders Daily
GNOM Dividend: 1.12% Yield, $0.65/Share — History & Dates - GuruFocus
GNOMZ ETF Profile: Dividends, Returns (AQUISUK:GNOMZ) - TradingView
Global X Genomics & Biotechnology ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.16666667 Sh - TradingView
Uniqure NV (QURE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pacific Biosciences of California Inc (PACB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Natera Inc (NTRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Qiagen NV (QGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Myriad Genetics Inc (MYGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Intellia Therapeutics Inc (NTLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrowhead Pharmaceuticals Inc (ARWR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beam Therapeutics Inc (BEAM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Allogene Therapeutics Inc (ALLO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Regenxbio Inc (RGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scilex Holding Co (SCLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Prime Medicine Inc (PRME) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio-Techne Corp (TECH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biontech SE (BNTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Legend Biotech Corp (LEGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Guardant Health Inc (GH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sana Biotechnology Inc (SANA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avidity Biosciences Inc (RNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Twist Bioscience Corp (TWST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vir Biotechnology Inc (VIR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Agilent Technologies Inc (A) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moderna Inc (MRNA) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
GNOM Archives - 24/7 Wall St.
ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026. - Pluang
ETF Showdown: ARKG vs GNOM, Which Genomics Fund Wins? - 24/7 Wall St.
ETFs Investing in Rocket Pharmaceuticals, Inc. Stocks - TradingView
Trading the Move, Not the Narrative: (GNOM) Edition - Stock Traders Daily
ETFs Investing in 10x Genomics Inc Class A Stocks - TradingView
GNOM ETF Profile: Dividends, Returns (NASDAQ:GNOM) - TradingView
ETFs Investing in Fulgent Genetics, Inc. Stocks - TradingView
3 of the best performing ASX ETFs to own right now - The Motley Fool Australia
GNOMGlobal X Genomics & Biotechnology ETF Revenue Breakdown - Finviz
Genomics & biotechnology ETF declares semi-annual distribution of $0.057900 - MSN
Global X Fds Genomics & Biotechnology Etf To Go Ex-Dividend On June 29th, 2026 With 0.05789 USD Dividend Per Share - Moomoo
Global X Genomics Biotechnology Etf Stock (GNOM) Financials Data
There is no financial data for Global X Genomics Biotechnology Etf (GNOM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):